Saturday, November 21, 2026

Choosing where to fill a prescription once meant simply picking a local pharmacy. While that option remains, consumers now have access to a growing array of digital platforms offering home delivery. Behind these services, companies are working to make the experience as seamless and transparent as possible.

The evolution of consumer-facing medication platforms was a central topic at MedCity News’ recent INVEST Digital Health Conference in Dallas, during a panel moderated by Shelley Bailey of the Independent Pharmacy Cooperative.

Pharmacies remain the most frequent touchpoint between consumers and the healthcare system. Yet historically, they have offered limited transparency regarding coverage, cost, and alternatives, according to Bethanie Baynes, director of payer relations and business development at Amazon Pharmacy.

“We see a clear need in this industry to put more agency in the hands of patients and members so they can see their options and make the best decision for themselves,” Baynes said.

Michelle Davey, CEO of care orchestration company Wheel, noted that when her company launched in 2018, consumer healthcare discussions centered largely on cash-pay models. Today, the focus has shifted to pricing transparency and helping consumers understand their benefits—including the cost differences between paying cash and using insurance. Davey emphasized that patients require support throughout their entire healthcare journey, not just at a single point, a holistic approach that encourages sustained engagement with digital tools.

Davey added that the point of care extends beyond a single interaction to include follow-up visits and medication adherence. The goal is ensuring patients receive necessary care both immediately and over time, which requires integrating the fragmented components of the healthcare system.

Currently, prescriptions can be filled, dispensed, and received through numerous channels, said Jessin Joseph, vice president of PBA markets at Judi Health, a pharmacy benefit administrator and medical claim adjudication platform. Historically, stakeholders such as pharmaceutical companies and pharmacy benefit managers have operated in silos. Judi Health aims to reduce the burden on patients by enabling them to see where a drug can be dispensed and what each option costs, integrated with their specific pharmacy benefit.

“There is no reason why people should have to call every different pharmacy to figure out the cost of a drug,” Joseph said.

Baynes highlighted that innovation also lies in simplifying navigation so patients avoid arriving at a pharmacy counter only to discover a drug is unavailable or not covered. Amazon Pharmacy addresses this by delivering medications to patients’ homes with free shipping, regardless of Prime membership. This convenience is critical for those whose work schedules conflict with pharmacy hours, and reducing friction points directly supports medication adherence.

From an investment perspective, Thorsten Wirkes, managing director at Bertelsmann Healthcare Investments, said the trend toward direct-to-consumer (D2C) and direct-to-employer (D2E) offerings will persist, driven by consumer demand for convenience. These models shift more decision-making power to patients.

Technology must facilitate these decisions. Davey pointed to D2C platforms from pharmaceutical manufacturers for specific medicines, such as GLP-1 weight management drugs. In response, many employers now cover the cost of clinical care while directing employees to obtain the medication through cash-pay pharmacies like Eli Lilly’s LillyDirect or Novo Nordisk’s NovoCare Pharmacy, sometimes sharing the drug expense.

Davey observed this trend expanding to cardiometabolic drugs, including treatments for type 2 diabetes and hypertension. Wirkes identified two additional categories ripe for digital distribution: high list-price, low net-price products common in primary care—such as respiratory inhalers and migraine medicines—and drugs excluded from or not preferred on formularies.

“As consumers want more decision-making authority and have the need to be more involved, they require a different environment to operate in,” Wirkes said. “That is why we believe D2C and D2E employer platforms are here to stay and will be a significant part of the future healthcare ecosystem.”

Photo: Nick Fanion

Source link

Exit mobile version